Intrinsic Edge Capital Management’s Chemours CC Stock Holding History

Intrinsic Edge Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-30,000	Closed	-$1.52M	–	120
2017 Q3	$1.52M	Sell	30,000 -40,499	-57%	-$1.91M	0.3%	63
2017 Q2	$2.67M	Sell	70,499 -20,000	-22%	-$789K	0.83%	50
2017 Q1	$3.48M	Buy	90,499 +20,000	+28%	+$602K	1.07%	37
2016 Q4	$1.56M	Buy	+70,499	New	+$1.45M	0.66%	49

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Intrinsic Edge Capital Management's CC Position: Q4 2017 in Review

Intrinsic Edge Capital Management sold out of Chemours (CC) in Q4 2017, closing a stake of 30,000 shares — an estimated $1.52M sold.

Intrinsic Edge Capital Management first reported a position in CC in Q4 2016 and held it in 4 quarters. The position peaked at $3.48M in Q1 2017. 537 funds tracked by Wall St. Rank hold CC as of Q4 2017.

Intrinsic Edge Capital Management reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
Intrinsic Edge Capital Management sold 30,000 Chemours shares in Q4 2017, an estimated $1.52M.
Intrinsic Edge Capital Management first reported a position in Chemours in Q4 2016 and held it in 4 quarters.
Intrinsic Edge Capital Management's Chemours position peaked at $3.48M in Q1 2017.
537 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.